Inogen (INGN)
(Real Time Quote from BATS)
$6.64 USD
-0.41 (-5.82%)
Updated Apr 25, 2024 12:08 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Income Statements
Fiscal Year end for Inogen, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 316 | 377 | 358 | 308 | 362 |
Cost Of Goods | 189 | 224 | 182 | 170 | 190 |
Gross Profit | 127 | 154 | 176 | 138 | 172 |
Selling & Adminstrative & Depr. & Amort Expenses | 236 | 239 | 167 | 150 | 152 |
Income After Depreciation & Amortization | -109 | -85 | 9 | -12 | 20 |
Non-Operating Income | 7 | 2 | -1 | 7 | 4 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -102 | -83 | 9 | -5 | 24 |
Income Taxes | 0 | 1 | 15 | 1 | 3 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -102 | -84 | -6 | -6 | 21 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -102 | -84 | -6 | -6 | 21 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -91 | -62 | 31 | 7 | 34 |
Depreciation & Amortization (Cash Flow) | 18 | 24 | 22 | 19 | 14 |
Income After Depreciation & Amortization | -109 | -85 | 9 | -12 | 20 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 23.18 | 22.85 | 22.49 | 21.98 | 22.24 |
Diluted EPS Before Non-Recurring Items | -4.42 | -1.15 | -0.28 | -0.27 | 1.07 |
Diluted Net EPS (GAAP) | -4.42 | -3.67 | -0.28 | -0.27 | 0.94 |
Fiscal Year end for Inogen, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 75.90 | 83.97 | 83.64 | 72.16 |
Cost Of Goods | NA | 47.74 | 50.20 | 49.59 | 41.43 |
Gross Profit | NA | 28.16 | 33.76 | 34.04 | 30.73 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 57.14 | 80.49 | 45.81 | 52.64 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -28.98 | -46.73 | -11.77 | -21.91 |
Non-Operating Income | NA | 1.89 | 1.40 | 1.98 | 1.76 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -27.09 | -45.32 | -9.79 | -20.15 |
Income Taxes | NA | -0.53 | 0.40 | 0.04 | 0.20 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -26.56 | -45.72 | -9.83 | -20.35 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -26.55 | -45.72 | -9.83 | -20.35 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 23.31 | 23.23 | 23.15 | 23.01 |
Diluted EPS Before Non-Recurring Items | NA | -1.14 | -1.97 | -0.42 | -0.63 |
Diluted Net EPS (GAAP) | NA | -1.15 | -1.97 | -0.42 | -0.88 |